Clinical Trial

Using LUminoMark vs Coventional Practice for Targeted Axillary Surgery

Study acronym: LUCAS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study was to compare the use of LuminoMarkTM as a method of targeting axillary lymph nodes with other existing methods used in each institution, such as charcoal staining, needle targeting, and ultrasound-guided skin marking, in patients with breast cancer clinically suspected of metastasis, with or without clipping at the time of diagnosis, regardless of the presence or absence of neoadjuvant chemotherapy. By doing so, the investigators aimed to confirm the safety and usefulness of LuminoMarkTM as a targeting method.
Trial Details
NCT Number NCT06903429
Lead Sponsor Kyungpook National University Chilgok Hospital
Collaborators: Samsung Medical Center, Gangnam Severance Hospital, Chung-Ang University Hospital, Myongji Hospital, Soonchunhyang University Hospital
Conditions Breast Cancer, Axillary Lymph Nodes, Target Lesion
Enrollment 330 participants
Start Date 2025-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-30